Skip to main content

Table 2 Clinical manifestations of patients with methanol intoxication, stratified according to status of renal damage as AKI or non-AKI (n = 50)

From: Acute kidney injury and the risk of mortality in patients with methanol intoxication

Variable

AKI patients

(n = 33)

Non-AKI patients

(n = 17)

All patients

(N = 50)

P value

Latent period, hours

6.9 ± 13.2

2.4 ± 6.0

5.3 ± 11.4

0.191

Hypothermia, n (%)

12 (36.4)

3 (17.6)

15 (30.0)

0.171

Hypotension, n (%)

13 (39.4)

3 (17.6)

16 (32.0)

0.118

Bradycardia, n (%)

5 (15.2)

2 (11.8)

7 (14.0)

0.744

Blurred vision, n (%)

11 (33.3)

5 (29.4)

16 (32.0)

0.778

Blindness, n (%)

5 (15.2)

0 (0)

5 (10.0)

0.091

Photophobia, n (%)

1 (3.0)

1 (5.9)

2 (4.0)

0.626

Mydriasis, n (%)

5 (15.2)

1 (5.9)

6 (12.0)

0.339

Dyspnoea, n (%)

25 (75.8)

5 (29.4)

30 (60.0)

0.002**

Acute respiratory failure, n (%)

21 (63.6)

5 (29.4)

26 (52.0)

0.022*

Nausea/vomiting, n (%)

14 (42.4)

7 (41.2)

21 (42.0)

0.933

Gastrointestinal bleeding, n (%)

12 (36.4)

4 (23.5)

16 (32.0)

0.357

Abdominal pain, n (%)

10 (30.3)

3 (17.6)

13 (26.0)

0.334

Pancreatitis, n (%)

4 (12.1)

0 (0)

4 (8.0)

0.134

Hepatitis, n (%)

2 (6.1)

0 (0)

2 (4.0)

0.300

Glasgow coma scale score

9.5 ± 5.5

11.8 ± 5.2

10.3 ± 5.5

0.170

Deep coma, n (%)

14 (42.4)

4 (23.5)

18 (36.0)

0.187

  1. *P < 0.05 and **P < 0.01